Latest stories on LTRN
Liontown to acquire up to 100% of Centenario lithium project
Yahoo Finance63 · neutralm&a
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Lantern Pharma Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Lantern Pharma outlines Open Medicine AI spin-out amid $10B market outlook by 2030-2031
Seeking Alpha56 · neutralgeneral
Lantern Pharma Inc. (LTRN) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Lantern Pharma Forms Open Medicine AI Subsidiary Business
TipRanks56 · neutralproduct/pr
Lantern Pharma GAAP EPS of -$0.57 misses by $0.19
Seeking Alpha34 · bearishearnings
Lantern Pharma Inc. (LTRN) files 8-K
SEC 8-K50 · neutralgeneral
Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update
StockTitan53 · neutralearnings
Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET
StockTitan50 · neutralgeneral
Lantern Pharma Inc. (LTRN) files 8-K
SEC 8-K50 · neutralgeneral
Lantern Releases New Research Showing AI Shopping Recommendations Are Far More Stable Than Daily Tracking Suggests
PR Newswire57 · neutralproduct/pr
Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer
StockTitan63 · neutralproduct/pr
Lantern achieves SOC2 Type 1 compliance in 8 weeks, validating security-first approach to AI-native ERP
PR Newswire63 · neutralproduct/pr
Lantern Unveils Agentic Commerce Platform to Maximize Revenue in AI Shopping
PR Newswire63 · neutralproduct/pr
OrthAlign Announces First Cases with Lantern® ASC System, Eliminating the Economic Barriers of Robotic Technology
PR Newswire63 · neutralproduct/pr
Lantern and 4Pens Partner to Bring AI-Native Operations to Promotional Products
PR Newswire56 · neutralproduct/pr